Categories Earnings, Technology
Cognizant Q2 earnings preview: Weakness in Financial Services and Healthcare segments likely to continue
Cognizant Technology Solutions (NASDAQ: CTSH) is set to announce financial results for its second quarter of 2019 on Wednesday, July 31, after market close. The market expects the IT solutions provider’s Q2 earnings to drop to $0.92 per share from the year-ago earnings of $1.19 per share and revenue to increase to $4.14 billion from $4.01 billion reported in the prior-year quarter. Cognizant stock was trading down about 1% during midday today.
Read: Cognizant second quarter 2019 live earnings update
For the first quarter of 2019, Cognizant’s bottom line and top line missed Street’s predictions. The Teaneck, New Jersey-firm had guided second quarter revenue to be in the range of $4.11 billion to $4.15 billion, reflecting growth of 2.6% to 3.6%. The company slashed FY19 outlook citing the disappointing Q1 performance and sluggish growth predictions in Financial Services and Healthcare segments for the remainder of 2019. After the earnings report, shares of Cognizant plunged 11% the next day.
During the three months ended March 31, 2019, Cognizant registered double-digit growth in Products and Resources, as well as Communications, Media and Technology segments. However, Financial Services segment, which accounted for 35% of total revenue in Q1, dropped 2% hurt by the softness in banking and insurance clients. Healthcare, which accounted for 28% of total revenue, had a growth of 4%. As the company announced in May, this sluggishness is expected to continue in the Financial Services and Healthcare segments for the June quarter.
The learning curve for Brian Humphries, the new CEO who joined the company on April 1 this year, should be over by now. During the second quarter earnings conference call, investors will look out for his plans to overcome the headwinds that Cognizant is facing now.
With regards to a question on its banking clients, the company stated during the last earnings call that it neither expects a significant recovery nor deterioration with the three of big five banking clients moving into the second half of the year. The company added that the four healthcare companies involved in two large mergers resulted in some pullbacks during the first quarter, and this deterioration will continue in Q2 and prolong in the rest of the year also.
Related: Cognizant (CTSH) Q1 2019 earnings conference call transcript
Cognizant stock, which plummeted to a new 52-week low ($56.73) in May, had advanced 4% since the beginning of this year and slumped 19% in the trailing 12 months.
Most Popular
Microsoft (MSFT) reports higher revenue and profit for Q3 2024
Microsoft Corp. (NASDAQ: MSFT) on Thursday said its third-quarter 2024 earnings increased year-over-year, reflecting strong performance by the tech giant’s main operating segments. Third-quarter revenues came in at $61.86 billion,
GOOG, GOOGL Earnings: All you need to know about Alphabet’s Q1 2024 earnings results
Alphabet Inc. (NASDAQ: GOOG, GOOGL) reported its first quarter 2024 earnings results today. Revenues increased 15% year-over-year to $80.5 billion. Revenue growth was 16% in constant currency. Net income was
MRK Earnings: Merck Q1 2024 profit jumps on 9% revenue growth
Pharmaceutical company Merck & Co. Inc. (NYSE: MRK) reported a sharp increase in adjusted earnings for the first quarter of 2024, aided by an increase in revenues. First-quarter worldwide sales
Comments
Comments are closed.